U.S. stock futures were flat in early Thursday trading, signaling a muted open as investors digest a wave of mixed economic data, fresh earnings results, and heightened political drama involving ...

A structured, risk-based framework for pharmaceutical compounding that enhances quality, regulatory compliance, and process consistency.